Cargando…

Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa

Extensively drug-resistant tuberculosis (XDR-TB), defined as resistance to at least isoniazid (INH), rifampicin (RIF), a fluoroquinolone (FQ) and a second-line injectable drug (SLID), is difficult to treat and poses a major threat to TB control. The transmission dynamics and distribution of XDR Myco...

Descripción completa

Detalles Bibliográficos
Autores principales: Oostvogels, Selien, Ley, Serej D., Heupink, Tim H., Dippenaar, Anzaan, Streicher, Elizabeth M., De Vos, Elise, Meehan, Conor J., Dheda, Keertan, Warren, Rob, Van Rie, Annelies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453078/
https://www.ncbi.nlm.nih.gov/pubmed/35471145
http://dx.doi.org/10.1099/mgen.0.000815
_version_ 1784785064238776320
author Oostvogels, Selien
Ley, Serej D.
Heupink, Tim H.
Dippenaar, Anzaan
Streicher, Elizabeth M.
De Vos, Elise
Meehan, Conor J.
Dheda, Keertan
Warren, Rob
Van Rie, Annelies
author_facet Oostvogels, Selien
Ley, Serej D.
Heupink, Tim H.
Dippenaar, Anzaan
Streicher, Elizabeth M.
De Vos, Elise
Meehan, Conor J.
Dheda, Keertan
Warren, Rob
Van Rie, Annelies
author_sort Oostvogels, Selien
collection PubMed
description Extensively drug-resistant tuberculosis (XDR-TB), defined as resistance to at least isoniazid (INH), rifampicin (RIF), a fluoroquinolone (FQ) and a second-line injectable drug (SLID), is difficult to treat and poses a major threat to TB control. The transmission dynamics and distribution of XDR Mycobacterium tuberculosis (Mtb) strains have not been thoroughly investigated. Using whole genome sequencing data on 461 XDR-Mtb strains, we aimed to investigate the geographical distribution of XDR-Mtb strains in the Western Cape Province of South Africa over a 10 year period (2006–2017) and assess the association between Mtb sub-lineage, age, gender, geographical patient location and membership or size of XDR-TB clusters. First, we identified transmission clusters by excluding drug resistance-conferring mutations and using the 5 SNP cutoff, followed by merging clusters based on their most recent common ancestor. We then consecutively included variants conferring resistance to INH, RIF, ethambutol (EMB), pyrazinamide (PZA), SLIDs and FQs in the cluster definition. Cluster sizes were classified as small (2–4 isolates), medium (5–20 isolates), large (21–100 isolates) or very large (>100 isolates) to reflect the success of individual strains. We found that most XDR-TB strains were clustered and that including variants conferring resistance to INH, RIF, EMB, PZA and SLIDs in the cluster definition did not significantly reduce the proportion of clustered isolates (85.5–82.2 %) but increased the number of patients belonging to small clusters (4.3–12.4 %, P=0.56). Inclusion of FQ resistance-conferring variants had the greatest effect, with 11 clustered isolates reclassified as unique while the number of clusters increased from 17 to 37. Lineage 2 strains (lineage 2.2.1 typical Beijing or lineage 2.2.2 atypical Beijing) showed the large clusters which were spread across all health districts of the Western Cape Province. We identified a significant association between residence in the Cape Town metropole and cluster membership (P=0.016) but no association between gender, age and cluster membership or cluster size (P=0.39). Our data suggest that the XDR-TB epidemic in South Africa probably has its origin in the endemic spread of MDR Mtb and pre-XDR Mtb strains followed by acquisition of FQ resistance, with more limited transmission of XDR Mtb strains. This only became apparent with the inclusion of drug resistance-conferring variants in the definition of a cluster. In addition to the prevention of amplification of resistance, rapid diagnosis of MDR, pre-XDR and XDR-TB and timely initiation of appropriate treatment is needed to reduce transmission of difficult-to-treat TB.
format Online
Article
Text
id pubmed-9453078
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Microbiology Society
record_format MEDLINE/PubMed
spelling pubmed-94530782022-09-08 Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa Oostvogels, Selien Ley, Serej D. Heupink, Tim H. Dippenaar, Anzaan Streicher, Elizabeth M. De Vos, Elise Meehan, Conor J. Dheda, Keertan Warren, Rob Van Rie, Annelies Microb Genom Research Articles Extensively drug-resistant tuberculosis (XDR-TB), defined as resistance to at least isoniazid (INH), rifampicin (RIF), a fluoroquinolone (FQ) and a second-line injectable drug (SLID), is difficult to treat and poses a major threat to TB control. The transmission dynamics and distribution of XDR Mycobacterium tuberculosis (Mtb) strains have not been thoroughly investigated. Using whole genome sequencing data on 461 XDR-Mtb strains, we aimed to investigate the geographical distribution of XDR-Mtb strains in the Western Cape Province of South Africa over a 10 year period (2006–2017) and assess the association between Mtb sub-lineage, age, gender, geographical patient location and membership or size of XDR-TB clusters. First, we identified transmission clusters by excluding drug resistance-conferring mutations and using the 5 SNP cutoff, followed by merging clusters based on their most recent common ancestor. We then consecutively included variants conferring resistance to INH, RIF, ethambutol (EMB), pyrazinamide (PZA), SLIDs and FQs in the cluster definition. Cluster sizes were classified as small (2–4 isolates), medium (5–20 isolates), large (21–100 isolates) or very large (>100 isolates) to reflect the success of individual strains. We found that most XDR-TB strains were clustered and that including variants conferring resistance to INH, RIF, EMB, PZA and SLIDs in the cluster definition did not significantly reduce the proportion of clustered isolates (85.5–82.2 %) but increased the number of patients belonging to small clusters (4.3–12.4 %, P=0.56). Inclusion of FQ resistance-conferring variants had the greatest effect, with 11 clustered isolates reclassified as unique while the number of clusters increased from 17 to 37. Lineage 2 strains (lineage 2.2.1 typical Beijing or lineage 2.2.2 atypical Beijing) showed the large clusters which were spread across all health districts of the Western Cape Province. We identified a significant association between residence in the Cape Town metropole and cluster membership (P=0.016) but no association between gender, age and cluster membership or cluster size (P=0.39). Our data suggest that the XDR-TB epidemic in South Africa probably has its origin in the endemic spread of MDR Mtb and pre-XDR Mtb strains followed by acquisition of FQ resistance, with more limited transmission of XDR Mtb strains. This only became apparent with the inclusion of drug resistance-conferring variants in the definition of a cluster. In addition to the prevention of amplification of resistance, rapid diagnosis of MDR, pre-XDR and XDR-TB and timely initiation of appropriate treatment is needed to reduce transmission of difficult-to-treat TB. Microbiology Society 2022-04-26 /pmc/articles/PMC9453078/ /pubmed/35471145 http://dx.doi.org/10.1099/mgen.0.000815 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License.
spellingShingle Research Articles
Oostvogels, Selien
Ley, Serej D.
Heupink, Tim H.
Dippenaar, Anzaan
Streicher, Elizabeth M.
De Vos, Elise
Meehan, Conor J.
Dheda, Keertan
Warren, Rob
Van Rie, Annelies
Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
title Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
title_full Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
title_fullStr Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
title_full_unstemmed Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
title_short Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
title_sort transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the western cape province, south africa
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453078/
https://www.ncbi.nlm.nih.gov/pubmed/35471145
http://dx.doi.org/10.1099/mgen.0.000815
work_keys_str_mv AT oostvogelsselien transmissiondistributionanddrugresistanceconferringmutationsofextensivelydrugresistanttuberculosisinthewesterncapeprovincesouthafrica
AT leyserejd transmissiondistributionanddrugresistanceconferringmutationsofextensivelydrugresistanttuberculosisinthewesterncapeprovincesouthafrica
AT heupinktimh transmissiondistributionanddrugresistanceconferringmutationsofextensivelydrugresistanttuberculosisinthewesterncapeprovincesouthafrica
AT dippenaaranzaan transmissiondistributionanddrugresistanceconferringmutationsofextensivelydrugresistanttuberculosisinthewesterncapeprovincesouthafrica
AT streicherelizabethm transmissiondistributionanddrugresistanceconferringmutationsofextensivelydrugresistanttuberculosisinthewesterncapeprovincesouthafrica
AT devoselise transmissiondistributionanddrugresistanceconferringmutationsofextensivelydrugresistanttuberculosisinthewesterncapeprovincesouthafrica
AT meehanconorj transmissiondistributionanddrugresistanceconferringmutationsofextensivelydrugresistanttuberculosisinthewesterncapeprovincesouthafrica
AT dhedakeertan transmissiondistributionanddrugresistanceconferringmutationsofextensivelydrugresistanttuberculosisinthewesterncapeprovincesouthafrica
AT warrenrob transmissiondistributionanddrugresistanceconferringmutationsofextensivelydrugresistanttuberculosisinthewesterncapeprovincesouthafrica
AT vanrieannelies transmissiondistributionanddrugresistanceconferringmutationsofextensivelydrugresistanttuberculosisinthewesterncapeprovincesouthafrica